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Abstract
Castleman's disease is a clinicopathological entity associated with lymphoproliferation. We report
a case of a 71 year old gentleman who was initially clinically suspected to have lymphoma (owing
to clinical features at presentation), but was later histologically confirmed to have Castleman's
disease. This case report underlines the importance of definitive histological diagnosis in patients
with lympadenopathic presentation associated with systemic symptoms and the distinctiveness of
multicentric Castleman's disease from malignant lymphoma. In this report we also attempt to
provide new insight (through the review of medical literature) into the clinical features,
pathogenesis, diagnosis and treatment of this rare and relatively benign disorder.
Background
Castleman's disease(CD) is a heterogeneous group of
lymphoproliferative disorders of uncertain cause [1] pre-
senting with lymphadenopathy. It is histologically and
prognostically distinct from malignant lymph-node
hyperplasia. It was first described in a group of patients
with benign localised hyperplastic lymph-nodes in 1956
by Castleman et al [2].
Synonyms of Castleman's Disease
Angiofollicular Lymph-Node Hyperplasia, Giant Benign
Lymphoma, Giant Lymph-Node Hyperplasia, Lymphoid
Hamartoma
Case presentation
A 71 year old gentleman was referred to the geriatric clinic
of a district general hospital with a 2 month history of
lethargy, decreased appetite and marked weight loss. He
had no past medical history of note but had a brother who
had died of lymphoma. Examination revealed mild bilat-
eral cervical and axillary lymphadenopathy with no pal-
pable organomegaly. Routine investigations such as full
blood count and biochemical profile (including hepatic
function tests) were found to be within normal range
except for raised globulins (55 g/L) with a polyclonal
increase in gamma-globulins. However, myeloma was
excluded when serum protein electrophoresis detected no
monoclonal band.
Computerised tomography revealed widespread lym-
phadenopathy involving the neck, axillae, chest/mediasti-
num, abdomen and pelvis with mild to moderate
splenomegaly. Bone marrow aspiration and trephine
biopsy showed small lymphoid follicular aggregates. Exci-
sion biopsy of an axillary node was performed and this
was reported as a lymphoproliferative picture (increased
number of follicles containing amorphous hyaline mate-
rial and some small blood vessels) between simple reac-
tive changes and frank lymphoma, suggesting
Castleman's disease. He was referred to a haematologist
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and was commenced on steroid therapy which success-
fully induced disease remission and symptomatic relief.
Discussion
Castleman's disease(CD) is lymphoproliferative disorder
which is histologically characterised by angiofollicular
lymph-node hypertrophy [3]. It may be borne in mind in
the differential diagnoses of localised/diffuse lymphaden-
opathy with or without systemic manifestations. This case
report, together with a review of medical literature in
existence, attempts to provide new insight into this rather
rare and relatively benign disorder which, though mim-
icking lymphoma clinically, varies from the latter histo-
logically, prognostically and in its treatment options.
Localised CD is, by definition, localised to one site. It fea-
tures lymphoid hyperplasia associated with excessive ang-
iogenesis [1]. It is asymptomatic in over 50% of patients
[4] and is often discovered incidentally. Histological diag-
nosis requires lymph-node biopsy.
Multicentric CD is characterized by a predominantly lym-
phadenopathic presentation consistently involving
peripheral lymph-nodes and manifestations of multisys-
tem involvement. It is considered as a systemic B cell lym-
phoproliferation, probably arising in immunoregulatory
deficit, and resulting in the outgrowth of clonal B-cell
populations [1]. It is always symptomatic. Symptoms, pri-
marily a consequence of elevated Interleukin-6(IL-6) pro-
duction, are asthenia(65%), weight loss(67%) and
fever(69%) [3]. Polyadenopathy is common(84%) with a
mean of four sites involved and is often associated with
hepatosplenomegaly [3]. Histological diagnosis is made
upon biopsy of an excised peripheral lymph-node.
A POEMS (Peripheral polyneuropathy, Organomegaly,
Endocrinopathy,  Monoclonal gammopathy(M-Protein)
and  Skin signs) syndrome [5] is observed in 24% of
patients [3]. Some MCD forms are associated with
Kaposi's sarcoma displaying prominent vascular prolifer-
ation and characteristic lesions. MCD associated with
human immunodeficiency virus(HIV) infection is very
similar to MCD observed in non-HIV-infected patients,
except for the high prevalence of pulmonary symptoms
and for the stronger association with Kaposi's sarcoma
[6]. Progression to malignant lymphoma in MCD associ-
ated with HIV is frequent, and within a prospective cohort
study [7] of 60 HIV-infected patients with MCD, and a fol-
low-up period of 20 months, 14 patients(23%) developed
HHV8-associated non-Hodgkin lymphoma.
The aetiology of Castleman's disease is poorly understood
and no genetic or toxic factor has so far been identified.
The hypothesis of a viral infection has been raised and
several studies have suggested the role of human herpes-
virus 8 (HHV-8), already implicated in Kaposi's sarcoma.
In MCD, HHV-8 sequences were identified in 60–100% of
patients infected with HIV and in 20–41% in those who
were not [8,9]. These findings suggest two possibilities
concerning the genesis of CD: (i) the opportunistic pres-
ence of HHV-8, favoured by immune pertubations; and
(ii) the direct pathogenic role of HHV-8, in association
with dysregulation of cytokines. Recent studies support
the latter hypothesis by demonstrating that HHV-8 is able
to produce an IL-6 homologue, the interleukin reponsible
for the plasmacytosis and hypergammaglobulinaemia
seen in MCD.
Localised CD is treated by surgical excision which allows
full recovery without relapse in almost all cases. However,
no therapeutic consensus exists for MCD and diverse
treatments (surgery/corticotherapy/chemotherapy) are
used, often in combination [3]. Anti-interleukin-6 anti-
body has also been successfully tried in the alleviation of
systemic manifestations [10]. The five-year survival rate in
MCD is 82% [3] and this prognosis appears to be far bet-
ter than that encountered with malignant lymphomas.
Conclusion
This case report brings to light the importance of obtain-
ing definitive histological diagnosis in patients presenting
with lymphadenopathy and systemic symptoms. Multi-
centric Castleman's disease is a relatively uncommon
cause for such a presentation. Though clinically synony-
mous with lymphoma, it is an entity that is distinct from
malignant lymphoproliferative disorders histologically
and prognostically. It may be borne in mind as a differen-
tial diagnosis in lymphadenopathic presentations with
symptoms of systemic involvement.
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